SABS·78397T202·US·equity·Healthcare - Biotechnology-Activist
SABS (SAB BIOTHERAPEUTICS INC) is held by 41 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($16.9M), BALYASNY ASSET MANAGEMENT L.P. ($14.4M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($13M). Net institutional sentiment: Bullish.
See how SABS's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer